To know the effect of guggulu and churna in the management of Amavata w.s.r. to Rheumatoid Arthritis

A comparative clinical study to evaluate the effect of vatari guggulu and shatpushpadi churna with simhanada guggulu in the management of amavata w.s.r. to rheumatoid arthritis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050329

Enrollment

Registered

2023-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing for study Age group 30-70 years will be selected for the study Patients with signs and symptoms of Amavatar wsr. to Rheumatoid Arthritis as described in classical texts and fulfill the diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Patients not willing for the study. 2. Patients below age of 30 years and above 70 years of age. 3. Patients suffering from cardiac, respiratory, P.T.B. Malignancy, Patient already taking chemotherapy, radiotherapy. Pregnant and Lactating women. Allergy to the research drug or any other condition considered to be Unfit for enrollment in the trial.

Design outcomes

Primary

Measure	Time frame
Relief in symptoms of amavata after intervention of vatari guggulu and shatpushpadi churna with simhanada guggulu Morning stiffness Generalised body aches Reduced appetite Thirst Lethargy Indigestion Joints pain Constipation Disturbed sleep Burning sensation Nausea Timepoint: 6 weeks	—

Secondary

Measure	Time frame
Improving quality of lifeTimepoint: 6 Weeks	—

Countries

India

Contacts

Public ContactShivani

RGGPG AYURVEDIC COLLEGE PAPROLA H.P..

dranjana269@gmail.com9418312324

Outcome results